TREM1 and Parkinson disease: The current phenomenon that monocyte brain infiltration and SNpc inflammation are both inhibited by global TREM-1 depletion leads to the fascinating hypothesis that the benefits of TREM-1 antagonism might be largely attributed to blocking monocyte recruitment to the SNpc in PD model mice.